What Happened?
New York, NY-based Castor Appointed Andrew Sadler as Chief Product and Technology Officer
About the Company
Castor is a leading provider of clinical trial technology that automates the research process. Castor is helping Democratize Clinical Research and making DCTs scalable with EDC, eConsent, ePRO & eCOA + DCT integrations. These solutions enable researchers to easily capture and integrate data from any source and decentralize their trials. Highlights: -Build studies within hours leveraging pre-built templates -Integrate EMR/EHR, patient, clinician, device, and wearable data -90% of studies in Castor are built and pass UAT in less than 4 weeks, significantly faster than the industry benchmark More than 40,000 researchers across 90 countries are using Castor to supercharge their research. Castor`s platform has supported more than 8,500 studies that cover a broad range of disease areas including diabetes, cardiovascular disease, central nervous system (CNS), rare diseases, infectious diseases, and oncology.
About the Person
Andrew Sadler is Chief Product and Technology Officer at Castor. Previously, Andrew held various senior IT leadership roles in the industry.
Info Source
News
Short Profile